<DOC>
	<DOC>NCT01991223</DOC>
	<brief_summary>To evaluate the efficacy of dexmedetomidine for the prevention of catheter-related bladder discomfort</brief_summary>
	<brief_title>Dexmedetomidine for Catheter-related Bladder Discomfort</brief_title>
	<detailed_description>After transurethral bladder resection, large-sized foley catheter have been used for drainage of urine and residual blood. Because of urinary catheterization, patients usually experiences catheter-related bladder discomfort defined as a burning sensation with an urge to void or discomfort in the supra-pubic region caused by catheter- related bladder irritation. Dexmedetomidine is an alpha-2 antagonist and used as an analgesic agent. The investigators try to evaluate The efficacy of dexmedetomidine for the treatment of catheter-related bladder discomfort</detailed_description>
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>Patients scheduled for transurethral bladder resection ASA IIII Patient who disagrees to participate this investigation Patient with severe cardiovascular disease Patient with smallsized foley catheter (less than 18 Fr.) Patinets with any urinary tract obstructions Patient with hyperactive or neurogenic bladder Patients with chronic renal failure Patient with morbidly obese Patients with neurogenic disorder Patient with medications for chronic pain</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>